Ellipsis Research Group

Brooklyn, New York 11215

6 studies enrolling now · 9 studies all time

What they study most

Gout, Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis, Overweight or Obese, Recurrent Pericarditis, Tophaceous Gout, Type 2 Diabetes Mellitus (T2DM), Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants — Recruiting now
• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• A Study of Dotinurad Versus Allopurinol in Tophaceous Gout — Recruiting now
• A Study of Dotinurad Versus Allopurinol in Participants With Gout — Recruiting now
• Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus — Running, not enrolling
• A Pilot Study of KPL-914 in Recurrent Pericarditis — Completed